Recent evidence has highlighted a significant correlation between CRP levels and the development and progression of diabetes, particularly in individuals with type 2 diabetes mellitus (T2DM).[4,5] CRP, as a marker of inflammation, is significantly elevated in patients with T2DM and is closely associated with metabolic disorders such as insulin resistance (IR) and hyperlipidemia.[6–8]. This evidence concerns the gene CRP and metabolic disease.